Jonathan Nash
InvestorInvestment Principal at LifeArc Ventures
London
Writes $100K – $5M checks · typically $1.5M
Find your path to Jonathan
552 people in our graph share verified history with Jonathan — schools, employers, funds. One of them is your warm intro.
Deji SasegbonunlockedJonathan: together at Imperial College London (2009–2014)
×7Jonathan: together at UBS
Jonathan: together at Imperial College London
Jonathan: together at Lightcast
About
Joined as Investment Principal in 2024, responsible for new investments and portfolio companies. Formerly an Associate on the biotech team at M Ventures (Merck KGaA's venture arm), an Associate at UBS healthcare investment banking, and a life science specialist at L.E.K.; trained as a doctor with degrees from Imperial College London.
Experience
- LifeArc VenturesInvestment Principal | Biotech, MedTech and HealthTechcurrent2024 — presentLondon, United Kingdom
- EXCIVA GmbHBoard Observercurrent2025 — present
- AffectBoard Directorcurrent2025 — present
- AffectBoard Observer2024 — 2025
- Fluid Biomed Inc.Board Observercurrent2024 — present
- Cytospire Therapeutics LtdBoard Observercurrent2024 — present
- StealthBoard Observercurrent2024 — present
- Maxion TherapeuticsBoard Observercurrent2024 — present
- Surgery HeroBoard Observer2024
- LabGenius TherapeuticsLead Investor2023
- LightcastBoard Observer2023
- ImmuneBridgeBoard Observer2023
- M VenturesInvestment Associate | Biotech & Life Sciences2021 — 2023Amsterdam, Netherlands
- Rewind TherapeuticsBoard Observer2021 — 2023
- NanoSyrinxBoard Observer2021 — 2023
- UBSAssociate | Healthcare Investment Banking2021London, United Kingdom
- UBSAnalyst | Healthcare Investment Banking2019 — 2021London, United Kingdom
- L.E.K. ConsultingLife Science Specialist2018 — 2019London, United Kingdom
- UBSSummer Analyst | Healthcare Investment Banking2018London, United Kingdom
- NHSDoctor2015 — 2018London, United Kingdom
Skills & more
Problem SolvingFinancial AnalysisInvestment ManagementManagement ConsultingMedicineInvestment BankingBiotechnologyTherapeuticsVenture CapitalFinancial Modeling
From Jonathan's professional profile.
Colleagues at LifeArc Ventures
Chris Baker
Investment Principal at LifeArc Ventures
Clare Terlouw
Managing Partner / Head of LifeArc Ventures at LifeArc Ventures
Deborah Harland
Chair, LifeArc Ventures Investment Committee at LifeArc Ventures
Diana Röttger
Investment Principal at LifeArc Ventures
Etienne Cousin
Investment Associate at LifeArc Ventures
Ian Gilham
Chair of Board of Trustees at LifeArc Ventures
Matthew Lulham-Robinson
Investment Associate at LifeArc Ventures
Olivia Cavlan
Partner at LifeArc Ventures
Frequently asked questions
- Who is Jonathan Nash?
- Joined as Investment Principal in 2024, responsible for new investments and portfolio companies. Formerly an Associate on the biotech team at M Ventures (Merck KGaA's venture arm), an Associate at UBS healthcare investment banking, and a life science specialist at L.E.K.; trained as a doctor with degrees from Imperial College London.
- Where does Jonathan Nash work?
- Jonathan Nash is Investment Principal at LifeArc Ventures.
- What check size does Jonathan Nash write?
- Jonathan Nash typically writes checks of $100K – $5M.
- Where did Jonathan Nash go to school?
- Jonathan Nash studied at Imperial College London (Bachelor of Medicine, Bachelor of Surgery (MBBS)); Imperial College London (Bachelor of Science (BSc), Neuroscience).
Same school
Shared employers
Also worked at EXCIVA GmbH4
Also worked at Fluid Biomed Inc.3
Also worked at Cytospire Therapeutics Ltd4
Also worked at Lightcast7
Sean KendallPartner (Europe) at ARCH Venture PartnersBrad CrutchfieldExecutives in Residence at GENERAL INCEPTIONMatthew FrohnManaging Partner and Co-Founder at Longwall Venture Partners LLPCraig AsherManaging Director at OMX VenturesWouter MeulemanPartner at Illumina VenturesChristian UhrichPrincipal at M Ventures
+ 1 more